Gregory Eschenauer
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antifungal resistance and susceptibility 15
- Clostridium difficile and Clostridium perfringens research 4
- Epidemiology 18
- Fungal Infections and Studies 12
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Co-authors
- Peggy L. Carver (9 shared papers)Daryl D. DePestel (1 shared paper)Simon W. Lam (7 shared papers)Cornelius J. Clancy (6 shared papers)Brian A. Potoski (6 shared papers)Ryan K. Shields (6 shared papers)Burgunda V. Sweet (1 shared paper)M. Hong Nguyen (4 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Open Forum Infectious Diseases (5 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Clinical Microbiology (2 papers)Annals of Pharmacotherapy (2 papers)
- Partner nations
- United StatesTaiwanNew Zealand
In The Last Decade
Gregory Eschenauer
37 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Applied Microbiology and Biotechnology 143
- Molecular Medicine 190
- Infectious Diseases 476
- Epidemiology 440
- Clinical Biochemistry 88
Countries citing papers authored by Gregory Eschenauer
This map shows the geographic impact of Gregory Eschenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Eschenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Eschenauer more than expected).
Fields of papers citing papers by Gregory Eschenauer
This network shows the impact of papers produced by Gregory Eschenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Eschenauer. The network helps show where Gregory Eschenauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory Eschenauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 139 | |
| 2 | 2012 | 105 | |
| 3 | 2019 | 104 | |
| 4 | 2010 | 89 | |
| 5 | 2014 | 56 | |
| 6 | 2014 | 54 | |
| 7 | 2009 | 51 | |
| 8 | 2005 | 50 | |
| 9 | 2012 | 40 | |
| 10 | 2015 | 36 | |
| 11 | 2018 | 36 | |
| 12 | 2016 | 29 | |
| 13 | 2007 | 25 | |
| 14 | 2014 | 24 | |
| 15 | 2010 | 22 | |
| 16 | 2013 | 21 | |
| 17 | 2015 | 20 | |
| 18 | 2009 | 19 | |
| 19 | 2021 | 18 | |
| 20 | 2014 | 17 |
About Gregory Eschenauer
Gregory Eschenauer is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (12 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Use and Resistance (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Antibiotic Resistance in Bacteria (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (143 citations), Molecular Medicine (190 citations), Infectious Diseases (476 citations), Epidemiology (440 citations) and Clinical Biochemistry (88 citations). Gregory Eschenauer has collaborated with scholars based in United States, Taiwan and New Zealand. Frequent co-authors include Peggy L. Carver, Daryl D. DePestel, Simon W. Lam, Cornelius J. Clancy, Brian A. Potoski, Ryan K. Shields, Burgunda V. Sweet, M. Hong Nguyen, Twisha S Patel and Christine J. Kubin. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.